tirzepatide updates today ruling court on OFA Fires Back at FDA in Tirzepatide Case, Redactions Raise Questions as Decision Looms Buy Tirzepatide, FDA, and Compounding: Understanding

Pharm Res 15 , 188193 (1998)

Again, bear in mind that the choice between these medications often depends on individual patient factors, healthcare provider recommendations, and specific health goals

Research and clinical investigation have produced one of the most extensively characterised profiles of any dual incretin research compound available in Europe: The SURPASS-2 trial documented Tirzepatides superiority over Semaglutide 1mg across HbA1c reduction and body weight loss providing the first head-to-head clinical validation that dual GIPR and GLP-1R co-agonism produces superior metabolic outcomes to the best-in-class selective GLP-1R monoagonist, establishing Tirzepatide as the new efficacy benchmark in incretin pharmacology and generating significant research interest across EU institutions in the mechanistic basis of dual incretin superiority

If you haven't noticed shifts by this point, your GLP1R genetic variant (rs6923761) may influence your individual response rate, which is another reason genetic testing offers clarity